Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology

C Settembre, RM Perera - Nature Reviews Molecular Cell Biology, 2024 - nature.com
Every cell must satisfy basic requirements for nutrient sensing, utilization and recycling
through macromolecular breakdown to coordinate programmes for growth, repair and stress …

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

Y Li, TSM Lih, SM Dhanasekaran, R Mannan, L Chen… - Cancer Cell, 2023 - cell.com
Clear cell renal cell carcinomas (ccRCCs) represent∼ 75% of RCC cases and account for
most RCC-associated deaths. Inter-and intratumoral heterogeneity (ITH) results in varying …

A Rag GTPase dimer code defines the regulation of mTORC1 by amino acids

P Gollwitzer, N Grützmacher, S Wilhelm, D Kümmel… - Nature cell …, 2022 - nature.com
Amino acid availability controls mTORC1 activity via a heterodimeric Rag GTPase complex
that functions as a scaffold at the lysosomal surface, bringing together mTORC1 with its …

TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism

N Alesi, EW Akl, D Khabibullin, HJ Liu… - Nature …, 2021 - nature.com
Abstract Tuberous Sclerosis Complex (TSC) is caused by TSC1 or TSC2 mutations,
resulting in hyperactivation of the mechanistic target of rapamycin complex 1 (mTORC1) …

Glycoprotein nonmetastatic melanoma protein B: a key mediator and an emerging therapeutic target in autoimmune diseases

PS Tsou, AH Sawalha - The FASEB Journal, 2020 - Wiley Online Library
The glycoprotein nonmetastatic melanoma protein B (GPNMB, also known as osteoactivin)
is highly expressed in many cell types and regulates the homeostasis in various tissues. In …

Proteogenomic characterization of MiT family translocation renal cell carcinoma

Y Qu, X Wu, A Anwaier, J Feng, W Xu, X Pei… - Nature …, 2022 - nature.com
Microphthalmia transcription factor (MiT) family translocation renal cell carcinoma (tRCC) is
a rare type of kidney cancer, which is not well characterized. Here we show the …

Integrative clinical and molecular characterization of translocation renal cell carcinoma

Z Bakouny, A Sadagopan, P Ravi, NY Metaferia, J Li… - Cell reports, 2022 - cell.com
Translocation renal cell carcinoma (tRCC) is a poorly characterized subtype of kidney
cancer driven by MiT/TFE gene fusions. Here, we define the landmarks of tRCC through an …

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma

G Sun, J Chen, J Liang, X Yin, M Zhang, J Yao… - Nature …, 2021 - nature.com
TFE3-translocation renal cell carcinoma (TFE3-tRCC) is a rare and heterogeneous subtype
of kidney cancer with no standard treatment for advanced disease. We describe …

Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis

G Prakasam, A Mishra, A Christie… - The Journal of …, 2024 - Am Soc Clin Investig
Translocation renal cell carcinoma (tRCC) most commonly involves an ASPSCR1-TFE3
fusion, but molecular mechanisms remain elusive and animal models are lacking. Here, we …

TFEB and TFE3 drive kidney cystogenesis and tumorigenesis

C Di Malta, A Zampelli, L Granieri, C Vilardo… - EMBO Molecular …, 2023 - embopress.org
Abstract Birt‐Hogg‐Dubé (BHD) syndrome is an inherited familial cancer syndrome
characterized by the development of cutaneous lesions, pulmonary cysts, renal tumors and …